<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02785341</url>
  </required_header>
  <id_info>
    <org_study_id>APA2-IPC 2014-010</org_study_id>
    <nct_id>NCT02785341</nct_id>
  </id_info>
  <brief_title>Adaptated Physical Activity During Chemotherapy: Evaluation of the Psychological, Physiological and Biological Impact</brief_title>
  <acronym>APA2</acronym>
  <official_title>Adaptated Physical Activity During Chemotherapy: Evaluation of the Psychological, Physiological and Biological Impact</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Paoli-Calmettes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Paoli-Calmettes</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although treatments significantly increase the life expectancy of cancer patients, their&#xD;
      quality of life is more or less reduced. The development of supportive care, such as physical&#xD;
      activity, is one of the tools that should be promoted to maintain quality of life and reduce&#xD;
      treatment side effects, including fatigue.&#xD;
&#xD;
      This study was developed to understand the different biopsychosocial effects of a physical&#xD;
      activity program carried out with patients suffering from various types of cancers, and to&#xD;
      facilitate and improve the implementation of this type of activity in health care facilities.&#xD;
&#xD;
      Study randomized, controlled, cross-over intervention evaluating a 12-week supervised and&#xD;
      adapted physical activity program.&#xD;
&#xD;
      Participants were assigned to one of two groups: Group A which first follows a 12-week&#xD;
      physical activity program, then undergoes usual care for 12 additional weeks, or Group B,&#xD;
      which continues usual care for 12 weeks (control group) and then starts the physical activity&#xD;
      program for 12 additional weeks. Quality of life (with questionnaires for 2 groups) ,&#xD;
      well-being, fatigue, physical capacity, leptin concentration, goal setting and level of&#xD;
      physical activity are evaluated during this protocol.&#xD;
&#xD;
      By understanding the multidimensional effects of a physical activity program for various&#xD;
      cancer types, depending on the time of proposing the program, by evaluating the correlations&#xD;
      among all these variables, and by evaluating long-term effects, the IPCAPA study contributes&#xD;
      to identifying the physical activity program which will be effective, viable and feasible for&#xD;
      all patients undergoing chemotherapy, whatever the type of cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cancer is one of the leading causes of deaths in the world, with an estimated incidence of&#xD;
      14.1 million per year (2012) in the world, and 355,000 in France. Despite an increase in&#xD;
      survival rates after cancer treatment, the psychological impact of the diagnosis and the&#xD;
      aggressiveness of treatments such as chemotherapy tend to significantly decrease the quality&#xD;
      of life of patients during and after cancer care.&#xD;
&#xD;
      Helping patients to support regular treatment is a crucial point in increasing compliance&#xD;
      with treatment and thus increasing the cure rate, and many supportive care have been&#xD;
      developed and implemented. Physical activity, now regarded as a non-drug therapy, provides&#xD;
      many benefits, both in tertiary and secondary prevention during cancer treatment. Many&#xD;
      studies have shown a decrease in mortality with physical activity during and after treatment,&#xD;
      especially for breast, colon and prostate cancer. Regular physical activity during treatment&#xD;
      increases patients' quality of life, for many types of cancer. The prevalence of fatigue&#xD;
      during cancer is well described, as well as the need to effectively treat cancer related&#xD;
      fatigue in order to enable patients to better withstand their treatment. Within the last&#xD;
      decade, it has been pointed out that physical activity is one of the most efficient ways to&#xD;
      combat cancer related fatigue.&#xD;
&#xD;
      From a psychological point of view, physical activity can decrease anxiety, depression and&#xD;
      stress, and can also increase self-esteem, perceived control, and overall mental health.&#xD;
&#xD;
      Exercise physiologically increases physical capacity, strength, endurance and flexibility,&#xD;
      and decreases physical symptoms such as pain and nausea. Biologically, physical activity&#xD;
      often results in beneficial changes in the circulation level of adiponectin, leptin, insulin,&#xD;
      and C-reactive protein, especially during breast, prostate and gastric cancer. Overall,&#xD;
      physical activity during cancer treatment results in improvement in general quality of life,&#xD;
      including mental, physical and social dimensions.&#xD;
&#xD;
      Although physical activity during cancer treatment is known to induce many benefits,&#xD;
      depending on the cancer and the type of treatment, it is difficult to clearly investigate the&#xD;
      effects of physical activity during cancer and how they interact or are sequential.&#xD;
&#xD;
      A better understanding of the close relationship between the psychological and physiological&#xD;
      aspects might allow us to better understand the effects of physical activity during cancer.&#xD;
      Exercise programs used during cancer treatment vary from one study to another in their&#xD;
      duration, intensity and frequency. Furthermore, not all patients are included and not all&#xD;
      types of cancers and treatment are considered.&#xD;
&#xD;
      Our study, named Institut Paoli Calmettes Adapted Physical Activity, was developed to&#xD;
      understand the different biopsychosocial effects of a physical activity program carried out&#xD;
      with patients suffering from various type of cancers, and to facilitate and improve the&#xD;
      implementation of this type of activity in health care facilities.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Insufficient recruitment&#xD;
  </why_stopped>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Impact of physical activity on fatigue during chemotherapy</measure>
    <time_frame>From the inclusion in the protocol until week 24</time_frame>
    <description>Questionnaire MFI 20 (Multidimensional Fatigue Inventory)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physiological evaluation</measure>
    <time_frame>From the inclusion in the protocol until week 24</time_frame>
    <description>6-minute walk test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biological evaluation</measure>
    <time_frame>Leptin concentration realized from inclusion (week 1) then week 12 and week 24</time_frame>
    <description>Leptin level with a blood test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Immediate adaptated physical activity (Group A)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Group A began a physical activity program for 12 consecutive weeks from inclusion in the protocol, then underwent the usual care for 12 additional weeks.&#xD;
Then to complete five evaluations with several questionnaires, and 6-minute walk test every 6 weeks (T0, T1, T2, T3 and T4) and leptin level with a blood test every 12 weeks (T0, T2 and T4).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Without immediate adaptated physical activity (Group B)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Group B followed the usual care for 12 weeks then started the physical activity program for 12 additional weeks.&#xD;
Then to complete five evaluations with several questionnaires, and 6-minute walk test every 6 weeks (T0, T1, T2, T3 and T4) and leptin level with a blood test every 12 weeks (T0, T2 and T4).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaires every 6 weeks (T0, T1, T2, T3 and T4)</intervention_name>
    <description>Questionnaire MFI 20 Questionnaire life satisfaction Scale of measurement of the positive and negative affects Questionnaire QLQ-C30 (EORTC) Questionnaire on the personal goals</description>
    <arm_group_label>Immediate adaptated physical activity (Group A)</arm_group_label>
    <arm_group_label>Without immediate adaptated physical activity (Group B)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>6-minute walk test) every 6 weeks (T0, T1, T2, T3 and T4)</intervention_name>
    <arm_group_label>Immediate adaptated physical activity (Group A)</arm_group_label>
    <arm_group_label>Without immediate adaptated physical activity (Group B)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>leptin level with a blood test every 12 weeks (T0, T2 and T4)</intervention_name>
    <description>blood sample</description>
    <arm_group_label>Immediate adaptated physical activity (Group A)</arm_group_label>
    <arm_group_label>Without immediate adaptated physical activity (Group B)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient aged 18 years or more,&#xD;
&#xD;
          -  Performance status (WHO) â‰¤ 2&#xD;
&#xD;
          -  Ability to participate in the IPCAPA program and medical certification of no&#xD;
             contraindications to exercise&#xD;
&#xD;
          -  Availability and willingness to participate in the IPCAPA study for the duration of&#xD;
             the protocol&#xD;
&#xD;
          -  Affiliated to a social security system&#xD;
&#xD;
          -  Signed informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or breastfeeding woman.&#xD;
&#xD;
          -  Woman with childbirth ability without effective contraception.&#xD;
&#xD;
          -  Patient in emergency situations, adult subject to a measure of legal protection (major&#xD;
             trusteeship, guardianship or ward of court), or unable to consent.&#xD;
&#xD;
          -  Inability to undergo medical monitoring of the trial for geographical, social or&#xD;
             psychological reasons.&#xD;
&#xD;
          -  Inability to practice physical activity.&#xD;
&#xD;
          -  Planned surgery within 24 weeks of inclusion.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>CAPPIELLO Maria Antonietta, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Paoli-Calmettes</affiliation>
  </overall_official>
  <link>
    <url>http://www.institutpaolicalmettes.fr</url>
    <description>Institut PAOLI-CALMETTES</description>
  </link>
  <verification_date>May 2016</verification_date>
  <study_first_submitted>May 18, 2016</study_first_submitted>
  <study_first_submitted_qc>May 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 27, 2016</study_first_posted>
  <last_update_submitted>May 24, 2016</last_update_submitted>
  <last_update_submitted_qc>May 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>adapted physical activity</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

